- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate-to-Severe Plaque Psoriasis in South Africa
Total 122 results
-
SandozHexal AGCompletedChronic Stable Plaque PsoriasisGermany, Romania, Bulgaria, Czech Republic, Estonia, Hungary, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
-
Evelo Biosciences, Inc.CompletedPsoriasis | Plaque PsoriasisUnited Kingdom, Hungary, Poland, United States
-
Galderma R&DCompletedPlaque PsoriasisUnited States, Spain, Germany, Italy, Belgium, Canada, Hungary
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Canada, Germany, France, Spain, Poland
-
Hangzhou Highlightll Pharmaceutical Co., LtdRecruitingPlaque PsoriasisUnited States
-
AmgenRecruitingPlaque PsoriasisUnited States
-
Eli Lilly and CompanyCompletedPlaque PsoriasisPuerto Rico, United States, Germany, Poland, Japan, Canada
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
Bausch Health Americas, Inc.TerminatedPlaque PsoriasisUnited States, Belgium, Italy, Hungary, Poland, Australia, France, Greece, Russian Federation, Latvia, Canada
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Austria, Canada, Poland
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Puerto Rico, Canada
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Spain, Puerto Rico, Czechia, Canada, Germany, France, Poland, Hungary, Mexico, Russian Federation, Argentina, Netherlands
-
Janssen Research & Development, LLCActive, not recruitingPlaque Psoriasis | Scalp PsoriasisUnited States, Canada
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
AbbVieCompletedPlaque PsoriasisUnited States, Australia, Germany, Israel, Italy, Spain, Taiwan, United Kingdom
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
MedImmune LLCCompletedPlaque PsoriasisUnited States, Canada
-
Bristol-Myers SquibbRecruitingPlaque PsoriasisAustralia, Mexico, Canada, United Kingdom, France, Argentina, Japan, Poland, Spain, Korea, Republic of, Brazil, Germany, Romania
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisUnited States, Hungary, Malaysia, Czechia, Korea, Republic of, Guatemala, Poland, Vietnam, Canada, Iceland, Slovakia
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisGermany, United States, Hungary, Italy, Turkey, Korea, Republic of, United Kingdom, China, Taiwan, Poland, Canada, France, Australia, Spain, Argentina, Japan
-
TakedaRecruitingPlaque PsoriasisUnited States, Canada, Poland, Italy, Japan
-
Dermavant Sciences GmbHIQVIA BiotechCompletedPlaque PsoriasisUnited States, Canada
-
Cytos Biotechnology AGTerminatedModerate to Severe Allergic AsthmaUnited States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
-
AbbVie (prior sponsor, Abbott)CompletedPlaque PsoriasisUnited States, Canada
-
PfizerCompletedChronic Plaque PsoriasisUnited States, Poland, Canada
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompleted
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
SandozHexal AGCompletedPlaque Type PsoriasisUnited States, France, Bulgaria, Slovakia
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Dermavant Sciences GmbHIQVIA BiotechCompletedPlaque PsoriasisUnited States, Canada
-
University of SheffieldCompletedLong-term Physical Health Conditions | Mild to Moderate Anxiety and/or DepressionUnited Kingdom
-
Promius Pharma, LLCCompletedChronic Stable Plaque PsoriasisUnited States
-
Innovation Pharmaceuticals, Inc.CompletedChronic Stable Plaque PsoriasisUnited States
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United Kingdom, United States, Poland, Germany, Brazil, Spain, Taiwan, Hungary, Japan, Canada, Argentina, Australia
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Momenta Pharmaceuticals, Inc.CompletedPsoriasis | Chronic Plaque PsoriasisUnited States, Poland, Canada, Czechia, Estonia, Germany, Slovakia, Bulgaria, Latvia
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
AmgenCompletedPlaque PsoriasisUnited States, Poland, Canada, Germany, Estonia, Latvia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Tris Pharma, Inc.Forest LaboratoriesCompletedModerate to Severe Chronic Pain Due to Osteoarthritis of the KneeUnited States
-
AbbVieCompletedChronic Plaque PsoriasisUnited States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia